TriangleNCT01352286 · OUTCOME
Duration of Response (DOR), Progression Free Survival (PFS), Overall Survival (OS)
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- MEDIAN
- Unit
- median months
- Interval / dispersion
- 95% Confidence Interval
- Time frame
- DOR: Initial date of response to date of progressive disease or death PFS: Date of first T -cell infusion to earliest date of disease progression of death due to any cause OS: Date of first T-cell infusion to date of death from any cause.
What was measured
Calculated median DOR, PFS, OS
Analysis population: Participants who received NYESO-1ᶜ²⁵⁹T following ASCT
Groups in this outcome
NYESO-1ᶜ²⁵⁹T Cells
Participants who received NYESO-1ᶜ²⁵⁹T following ASCT
| Group | Source count |
|---|---|
| NYESO-1ᶜ²⁵⁹T Cells | 25 |
Reported measurements
DOR
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| NYESO-1ᶜ²⁵⁹T Cells | 12.2 | Not reported | 7.6 | 29.8 | Not reported |
PFS
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| NYESO-1ᶜ²⁵⁹T Cells | 13.5 | Not reported | 8.9 | 31.1 | Not reported |
OS
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| NYESO-1ᶜ²⁵⁹T Cells | 35.1 | Not reported | 22.7 | NA | The 95% upper confidence limits for median overall survival could not be calculated because of the high number/proportion (11 participants/44%) of participants alive at the time of the analysis. |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- lower Limit
- 7.6
- upper Limit
- 29.8
- value
- 12.2
- title
- DOR
- categories
- measurements
- group Id
- OG000
- lower Limit
- 8.9
- upper Limit
- 31.1
- value
- 13.5
- title
- PFS
- categories
- measurements
- comment
- The 95% upper confidence limits for median overall survival could not be calculated because of the high number/proportion (11 participants/44%) of participants alive at the time of the analysis.
- group Id
- OG000
- lower Limit
- 22.7
- upper Limit
- NA
- value
- 35.1
- title
- OS
- denoms
- counts
- group Id
- OG000
- value
- 25
- units
- Participants
- description
- Calculated median DOR, PFS, OS
- dispersion Type
- 95% Confidence Interval
- groups
- description
- Participants who received NYESO-1ᶜ²⁵⁹T following ASCT
- id
- OG000
- title
- NYESO-1ᶜ²⁵⁹T Cells
- param Type
- MEDIAN
- population Description
- Participants who received NYESO-1ᶜ²⁵⁹T following ASCT
- reporting Status
- POSTED
- time Frame
- DOR: Initial date of response to date of progressive disease or death PFS: Date of first T -cell infusion to earliest date of disease progression of death due to any cause OS: Date of first T-cell infusion to date of death from any cause.
- title
- Duration of Response (DOR), Progression Free Survival (PFS), Overall Survival (OS)
- type
- SECONDARY
- unit Of Measure
- median months
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice